论文部分内容阅读
本文报告86例恶性淋巴瘤患者(50例为Ⅲ或Ⅳ期的淋巴网细胞瘤,36例为非淋巴网细胞淋巴瘤),由于脾脏功能的亢进而导致血细胞减少,影响化疗或放射治疗。 86例患者中有84例进行了脾切除术,结果使78％淋巴网细胞瘤和75％非淋巴网细胞淋巴瘤患者获得完全或部分缓解,Ⅲ期和Ⅳ期的淋巴网细胞瘤患者,有33例(66％)取得完全缓解,6例(12％)部分缓解。Ⅲ期患者脾切后的平均病程达51个月,Ⅳ期患者为41个月。非淋巴网细胞淋巴瘤的完全缓解率为50％。脾切
This article reports 86 cases of malignant lymphoma (50 cases of stage Ⅲ or Ⅳ lymphocytoma, 36 cases of non-lymphocytic lymphoma), due to hyperactivity of the spleen caused by cytopenias, the impact of chemotherapy or radiation therapy. Of the 86 patients, 84 had undergone splenectomy resulting in complete or partial remission in 78% of lymphocytoma and 75% of non-lymphocytic lymphoma patients. Patients with stage III and IV lymphoblastoma have 33 patients (66%) achieved complete remission, 6 patients (12%) partially relieved. The mean duration of splenectomy in stage III patients was 51 months and in stage IV patients was 41 months. The complete remission rate of non-lymphocytic lymphoma was 50%. Spleen cut